Franklin Resources Inc. increased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 6.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,148,185 shares of the business services provider's stock after purchasing an additional 252,674 shares during the quarter. Franklin Resources Inc. owned approximately 2.35% of Genpact worth $162,318,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Advisors Asset Management Inc. grew its holdings in Genpact by 3.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider's stock worth $270,000 after acquiring an additional 226 shares during the last quarter. Lecap Asset Management Ltd. boosted its stake in shares of Genpact by 2.1% in the 3rd quarter. Lecap Asset Management Ltd. now owns 18,059 shares of the business services provider's stock valued at $708,000 after purchasing an additional 364 shares during the last quarter. Suncoast Equity Management boosted its stake in shares of Genpact by 3.1% in the 3rd quarter. Suncoast Equity Management now owns 12,600 shares of the business services provider's stock valued at $494,000 after purchasing an additional 375 shares during the last quarter. Sawyer & Company Inc boosted its stake in shares of Genpact by 1.1% in the 3rd quarter. Sawyer & Company Inc now owns 36,243 shares of the business services provider's stock valued at $1,421,000 after purchasing an additional 400 shares during the last quarter. Finally, United Services Automobile Association boosted its stake in shares of Genpact by 3.3% in the 2nd quarter. United Services Automobile Association now owns 13,388 shares of the business services provider's stock valued at $431,000 after purchasing an additional 433 shares during the last quarter. 96.03% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Jefferies Financial Group upped their price objective on shares of Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. TD Cowen increased their target price on shares of Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, November 8th. Needham & Company LLC increased their target price on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research note on Monday, November 11th. JPMorgan Chase & Co. increased their target price on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, Robert W. Baird increased their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $42.33.
Read Our Latest Report on G
Insiders Place Their Bets
In other news, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.80% of the company's stock.
Genpact Stock Down 2.3 %
Shares of G stock traded down $1.03 on Monday, hitting $43.64. The stock had a trading volume of 2,112,869 shares, compared to its average volume of 1,352,131. The stock has a market cap of $7.70 billion, a price-to-earnings ratio of 11.99, a price-to-earnings-growth ratio of 1.56 and a beta of 1.18. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98. The business has a 50 day moving average of $42.46 and a 200 day moving average of $37.89.
Genpact Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be given a $0.1525 dividend. This represents a $0.61 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Monday, December 9th. Genpact's dividend payout ratio is 16.76%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.